CIK 0001062822
- Non-accelerated filer
- Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760474169
- Phone
- +1 281-863-3000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-28 | MAIN ALAN J EVP, Innov & Chem Sciences | Exercise or conversion · Restricted Stock Units | −23,300 | 0 | ||
| 2023-02-28 | MAIN ALAN J EVP, Innov & Chem Sciences | Exercise or conversion · Restricted Stock Units | −8,976 | 8,977 | ||
| 2023-02-28 | MAIN ALAN J EVP, Innov & Chem Sciences | Exercise or conversion · Restricted Stock Units | −25,667 | 51,333 | ||
| 2023-02-28 | Kassler-Taub Kenneth B. SVP, Regulatory & QA | Exercise or conversion | +18,243 | 104,100 | ||
| 2023-02-28 | Kassler-Taub Kenneth B. SVP, Regulatory & QA | Exercise or conversion | +7,086 | 111,186 | ||
| 2023-02-28 | Kassler-Taub Kenneth B. SVP, Regulatory & QA | Exercise or conversion | +27,557 | 138,743 | ||
| 2023-02-28 | Kassler-Taub Kenneth B. SVP, Regulatory & QA | Shares withheld for taxes | −19,118 | $2.17 | $41K | 119,625 |
| 2023-02-28 | Kassler-Taub Kenneth B. SVP, Regulatory & QA | Exercise or conversion · Restricted Stock Units | −18,243 | 0 | ||
| 2023-02-28 | Kassler-Taub Kenneth B. SVP, Regulatory & QA | Exercise or conversion · Restricted Stock Units | −7,086 | 7,087 | ||
| 2023-02-28 | Kassler-Taub Kenneth B. SVP, Regulatory & QA | Exercise or conversion · Restricted Stock Units | −27,557 | 55,113 | ||
| 2023-02-28 | Granowitz Craig B SVP, Chief Medical Officer | Exercise or conversion | +27,917 | 27,917 | ||
| 2023-02-28 | Granowitz Craig B SVP, Chief Medical Officer | Shares withheld for taxes | −12,732 | $2.17 | $28K | 15,185 |
| 2023-02-28 | Granowitz Craig B SVP, Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −27,917 | 55,833 | ||
| 2023-02-28 | Crum Brian T SVP, General Counsel & Secr. | Exercise or conversion | +21,030 | 120,488 | ||
| 2023-02-28 | Crum Brian T SVP, General Counsel & Secr. | Exercise or conversion | +8,750 | 129,238 | ||
| 2023-02-28 | Crum Brian T SVP, General Counsel & Secr. | Exercise or conversion | +26,097 | 155,335 | ||
| 2023-02-28 | Crum Brian T SVP, General Counsel & Secr. | Shares withheld for taxes | −20,537 | $2.17 | $45K | 134,798 |
| 2023-02-28 | Crum Brian T SVP, General Counsel & Secr. | Exercise or conversion · Restricted Stock Units | −21,030 | 0 | ||
| 2023-02-28 | Crum Brian T SVP, General Counsel & Secr. | Exercise or conversion · Restricted Stock Units | −8,750 | 8,750 | ||
| 2023-02-28 | Crum Brian T SVP, General Counsel & Secr. | Exercise or conversion · Restricted Stock Units | −26,097 | 52,193 |
Page 19 of 27 · 540 trades